ON101 Named Among the Global Top 15 in the ADA 2026 Innovation Challenge 2026-05-29
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by Health Canada. 2026-05-11
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by ThaiFDA. 2026-05-11
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by AMMPS Morocco. 2026-04-10
EU NB issued the EU market approval for Bonvadis® that grants marketing authorization across all 27 EU member states for acute and chronic wounds, and scar management. 2026-03-12
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia. 2026-02-22
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia. 2026-01-31

Bonvadis^® is a topical product containing proprietary natural herbal ingredients for wound bed optimization and healing, enabling fast healing in simplicity.

The combination of “Bon” (‘good’ in French) and “vadízo̱” (‘walk’ in Greek) is the origination of the Bonvadis^® product name, representing Oneness’ confidence in restoring patients’ ability to walk (limb salvage).

..

About Us
Tel : +886-2-2703-1098 (Taiwan)
Fax : +886-2-2703-1200
Email : bonvadis@onenessbio.com.tw
Add : 35F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City, Taiwan (R.O.C.)

YouTube
LinkedIn
Link